Indication
Herpes Simplex Virus
4 clinical trials
4 products
Product
PritelivirClinical trial
Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects With Treatment Resistant Herpes Simplex Virus Type 1 or 2Status:
Clinical trial
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareStatus: Completed, Estimated PCD: 2019-11-01
Product
POPSClinical trial
Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy VolunteersStatus: Recruiting, Estimated PCD: 2024-01-30
Product
IM-250Clinical trial
Phase 1 Trial of Engineered HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsStatus: Active (not recruiting), Estimated PCD: 2025-09-01
Product
G207